Two patients treated with levamisole for rheumatoid arthritis each developed a lichenoid skin eruption. In both patients the rash subsided when the drug was stopped, but one patient was .left with severe scarring alopecia of the scalp, and widespread atrophic and hyperpigmented lesions over his skin a year later. No previous cases have been reported in the literature.
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Case 1
A man aged 59 years developed seropositive rheumatoid arthritis in 1969. His hands, feet, knees and elbows were severely affected, and he subsequently developed vasculitis affecting his fingertips. In 1972 he was prescribed hydroxychloroquine (Plaquenil) 200 mg three times a day, as simple anti-inflammatory drugs had proved ineffective in controlling his symptoms. He complained of generalized pruritus during the eighteen months that he took hydroxychloroquine, but no rash appeared.
In 1974 treatment with n-penicillamine was started and the dosage gradually increased to a maximum of one gram daily. After four months he stopped this medication and no further penicillamine was given. During the following seventeen months his rheumatoid disease became more active and vasculitic lesions appeared once again on his fingertips. However, he was able to return to work after taking levamisole 50 mg three times daily for six weeks. After two months on levamisole he complained of generalized pruritus. His skin became scaly and clinically resembled a mild lamellar ichthyosis, which was most noticeable on his trunk and limbs. Over the shoulders, buttocks and in the antecubital fossae the skin was thickened and appeared eczematous. An emollient cream produced moderate relief of his symptoms, but one month later widespread asteatotic eczema was seen over the shoulders, elbows and abdomen.
He complained of scaling and irritation of his scalp, and four weeks later profuse hair loss developed. At this time moist brown crusted plaques were evident over his chest and back, together with hypertrophic papulonodular lesions on the scalp (Figures I & 2) . There was also marked enlargement of axillary and inguinal lymph nodes. A superficial erosion appeared on the left labial buccal mucosa. At this stage the levamisole was discontinued. Biopsies were taken from the scalp and chest skin, and an axillary lymph node was removed. Two weeks later a further biopsy was taken from the right scapular region. Four months later his clinical appearance was unchanged. Repeat biopsies were taken from the scalp and trunk. Eight months after stopping levamisole, scarring alopecia of the scalp and atrophic lichenoid plaques on the trunk and limbs remained. After one year the plaques became hyperpigmented (Figure 3 ), but no regrowth of hair had occurred on any part of the scalp.
Histology: Skin from the trunk showed some follicular plugging and a patchy dermal infiltrate, as well as destruction of the basal layers of the epidermis and hydropic degeneration of keratinocytes. A repeat biopsy six weeks later showed that the infiltrate had become more band-like beneath the epidermis.
The initial scalp biopsy also showed follicular plugging, together with a sparse dermal infiltrate that was less obvious than that seen on the first biopsy from the trunk. Direct immunofluorescence of lesional skin showed extracellular clumps of colloid bodies which stained brightly with IgG, IgA, IgM and C 3 in the papillary dermis. Normal skin showed cell membrane deposition of IgG. Six months later a repeat biopsy from the scalp showed a substantial lossof hair follicles with an atrophic epidermis. There was pigmentary incontinence and scarring in the dermis.
The axillary lymph node biopsy showed reactive changes only, compatible with a . dermatopathic lymphadenopathy.
Investigations: the following were normal: Hb, WBC, differential, urea and electrolytes, liver function tests, calcium, phosphate, proteins, electrophoresis. Coombs test negative at 1/100; DNA binding 7%. The following investigations were abnormal: ANF positive 1/100; rheumatoid factor latex positive 1/160.
Case2
In February 1976 a 51-year-old female with an eight-year history of active sero-negative rheumatoid arthritis, but associated with typical radiological changes, was prescribed levamisole 50 mg daily. Within four months linear hyperkeratotic lesions were noted along the medial aspect of the right calf. Two months later the typical changes of hypertrophic lichen planus were seen on the right lower leg, and reticulate lesions were present in the mouth and on the lower lip. Over a three-month period new lesions appeared on the right thigh and over the left wrist. After ten months levamisole was stopped; the lesions flattened and became hyperpigmented within two months.
Investigations: Biopsy from the left wrist in January 1977 showed features of lichen planus but with several colloid bodies high in the epidermis (Figure 4) . ANF was positive 1/1000. Normal investigations were: Hb, WBC, differential, ESR, rheumatoid factor negative, DNA binding. 
Discussion
Levamisole was developed originally for use as an anti helminthic agent, but was later noted to have the property of altering defective immune responsiveness in a variety of disease states (Ramot et al. 1976) . It is known to be an effective drug in the treatment of rheumatoid arthritis (Huskisson et al. 1976 , Verhaegen et al. 1977 .
With the-use of penicillamine-like drugs, such as gold and the antimalarials, the response in rheumatoid arthritis is delayed, taking several months to produce any noticeable clinical effect. This delayed reaction has led to speculation that this group of agents may share a common mode of action as irnmunomodulators (Currey 1977) .
Toxic reactions are common with all three drugs, and skin reactions form a major criterion for the withdrawal of therapy with gold and penicillamine (Jaffe 1977) . Erosion of the buccal mucosa is commonly seenin patients with rheumatoid arthritis treated with penicillamine, levamisole and gold. Erosive lichen planus has occurred in one patient on levamisole and in two patients on penicillamine (T Lehner, personal communication). Gold used in the treatment of rheumatoid arthritis has long since been recognized to induce lichenoid eruptions (Meara 1953 , Penneys et al. 1974 . Lichen planus has also been documented in a patient treated with penicillamine for rheumatoid arthritis (van de Staak et al. 1975) .
A scaling psoriasiform type of eruption or a rash resembling asteatotic eczema is commonly seen on the limbs of patients treated with levamisole for several months. Gold may produce generalized eczema or exfoliative dermatitis after many months of therapy for rheumatoid arthritis, necessitating withdrawal of the drug. Antimalarial prophylaxis was recognized during World War II as being capable of inducing eczema and lichen planus in many soldiers (Wilson 1946) . Our first case developed eczematous changes initially but these gradually merged into a more obvious lichen planus-like eruption.
There is evidence to suggest that patients with rheumatoid arthritis differ immunologically from a control population, a reduction of T-cell function (Lance & Knight 1974) or a T-cell suppressor activity (Allison et af. 1971) being reported. The range of toxic reactions which occur in patients with rheumatoid arthritis when treated with penicillamine and levamisole tend not to be seen in patients in whom these drugs are used for other conditions. Of a group of 150 patients treated with levamisole for aphthous ulcers or Behcet's syndrome, no case of lichen planus has been seen (T Lehner, personal communication) .
It has been suggested that penicillamine may activate suppressor T cells (Maini & Roffe 1976), and Harth et af. (1977) have shown in vitro that gold has an effect on T-cell response. Levamisole has been shown to alter significantly the number of null cells in patients with rheumatoid arthritis ; it also increases the number of E rosette forming 'lymphocytes in rheumatoid arthritis (Verhaegen et af. 1977) . The response of T lymphocytes to phytohaemagglutinin is diminished in rheumatoid disease, and this defect can be corrected in those subjects treated with levamisole. Many of the properties of levamisole have been compared with those of thymic hormone obtained from patients with myasthenia gravis. Both compounds have an effect on cholinergic nerve endings. Intracellular cyclic nucleotide levels are altered in a comparable fashion by each compound and, as a consequence, cellular activities such as secretion, phagocytosis and movement are enhanced.
It is of interest that three patients with myasthenia gravis and two with thymomata have been reported to have severe erosive lichen planus (Aaronson et al. 1978 ). Tan et af. (1975 showed that within the cellular infiltrate of lichen planus T cells predominate. Saurat & Gluckman (1977) reported lichen planus-like eruptions in patients who developed graftversus-host skin disease following bone marrow transplantation.
In summary, it would appear that alteration of T cell function may well improve the joints of patients treated with penicillamine-like drugs for rheumatoid arthritis. On the other hand, many patients treated with these drugs develop psoriasiform or eczematous eruptions which may progress to a lichen planus-like eruption. It is possible that altered epidermal influences may trigger T cells to take part in the lichenoid infiltrate. It can be predicted that a proportion of the patients in whom cell-mediated responses are altered by such compounds will inevitably develop a lichen planus-like eruption.
